News & Breakthroughs at Siteman
Stay informed with the latest cancer news and breakthroughs from Siteman Cancer Center. Our news feed provides timely updates on research breakthroughs, clinical trials, and community events.
In the Media News & Stories
In the Media, Staff/Faculty Update
NCCN Recognizes Podany as 2026 Young Investigator Award Recipient
WashU Medicine physician-scientist Emily L. Podany, MD, MPHS, has been named a 2026 recipient of a prestigious NCCN Foundation Young Investigator Award, given by the National Comprehensive Cancer Network (NCCN) and NCCN Foundation. Podany is an assistant professor of medicine at WashU Medicine and a medical oncologist who treats patients diagnosed with breast cancer at Siteman Cancer Center, based at Barnes-Jewish […]
Clinical, In the Media, Research
Tumor Markers May Help Doctors Decide Which Head and Neck Cancer Patients Need Immunotherapy Before Surgery
WashU Medicine physician-scientists at Siteman Cancer Center identify a promising way to help guide immunotherapy treatment decisions and enhance patient care Building upon more than a decade of investigator-initiated clinical trials at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, researchers have identified a malignant cell biomarker that may predict which patients will respond to the […]
Clinical, In the Media, Research
Innovative CAR-T cell therapy receives FDA breakthrough therapy designation
Immunotherapy for aggressive T-cell cancers developed by WashU Medicine researchers moves to faster approval pathway A cell-based immunotherapy designed to treat rare and aggressive types of blood cancer has been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration (FDA). Developed by researchers at Washington University School of Medicine in St. Louis, this […]
In the Media, Staff/Faculty Update
Stewart Elected to AACR Board of Directors
Sheila A. Stewart, PhD, associate director for basic science and co-leader of the Mechanisms of Cancer Biology Program at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, has been elected to the American Association for Cancer Research (AACR) Board of Directors. Stewart, who is also the Gerty Cori Professor and vice chair of the […]
In the Media
Hockey and Hope: Siteman Teams Up with St. Louis Blues Alumni for Third Annual Benefit Game
Led by Kelly Chase, the March 27 event brings NHL legends and special guests together to raise funds for cancer research, patient care and lifesaving advances. Siteman Cancer Center is honored to once again be a beneficiary of the annual St. Louis Blues alumni game led by Kelly Chase, returning for its third year on […]
In the Media, Research, Staff/Faculty Update
Grant Furthers Novel Therapeutic Approach to Glioblastoma
Mosquito-borne Zika virus helps destroy deadly brain cancer in mice Milan G. Chheda, MD, an associate professor of medicine in the Division of Oncology at WashU Medicine and a brain tumor specialist at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine, has received a nearly $1.5 million grant from the Robert J. Kleberg, […]
Clinical, In the Media, Research
FDA Breakthrough Therapy Designation Reflects Practice-Changing Trends Only at Siteman
Recognition follows strong early clinical results for a novel off-the-shelf CAR T therapy targeting rare and aggressive T-cell malignancies A novel off-the-shelf CAR T-cell therapy pioneered at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine is gaining national recognition after delivering striking clinical results in patients with rare and aggressive blood cancers. The FDA […]
In the Media
FDA Grants Breakthrough Therapy Designation to Treatment for Rare Blood Cancers
Recognition follows strong early clinical results for a novel off-the-shelf CAR T therapy targeting rare and aggressive T-cell malignancies A novel off-the-shelf CAR T-cell therapy pioneered at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine is gaining national recognition after delivering striking clinical results in patients with rare and aggressive blood cancers. The FDA […]
In the Media, Research
New Imaging Approach Reduces Unnecessary Breast Biopsies by Nearly 25%
WashU researchers at Siteman Cancer Center are advancing breast imaging to help patients avoid invasive procedures and improve the screening experience In a new discovery at Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine, a team of researchers and physicians found that utilizing ultrasound-guided diffuse optical tomography technology can reduce unnecessary breast biopsy rates by nearly […]
In the Media
Siteman Investment Program Awards $2.44 Million for Cancer Research
Siteman Cancer Center at Barnes-Jewish Hospital and WashU Medicine is pleased to announce funding for 13 new projects, including two clinical trials and community outreach and engagement efforts. Through this research, investigators aim to improve the understanding of tumor formation and growth, develop safer, more effective therapies, and remove barriers to precision medicine. The funding […]